Postinflammatory hyperpigmentation
Ang Postinflammatory hyperpigmentation ay isang kondisyon ng balat na nailalarawan sa pagtaas ng pigment sa balat kasunod ng pamamaga ng balat. Ang postinflammatory hyperpigmentation ay maaaring sanhi ng matagal na pagkakalantad sa araw, pamamaga, o iba pang pinsala sa balat, kabilang ang mga nauugnay sa acne. Ang mga taong may mas madidilim na kulay ng balat ay kadalasang mas madaling kapitan ng hyperpigmentation na may labis na pagkakalantad sa araw.
☆ Sa 2022 na mga resulta ng Stiftung Warentest mula sa Germany, ang kasiyahan ng consumer sa ModelDerm ay bahagyang mas mababa kaysa sa mga bayad na konsultasyon sa telemedicine.
References
Ang Postinflammatory hyperpigmentation (PIH) ay isang madalas na problema sa balat na nangyayari pagkatapos ng pamamaga o pinsala sa balat. Ito ay may posibilidad na tumagal ng mahabang panahon at mas malala sa mga taong may mas madidilim na kulay ng balat (Fitzpatrick skin types III–VI) . Bagama't madalas itong bumubuti nang mag-isa, maaaring tumagal ito ng ilang sandali, kaya madalas na kailangan ang paggamot sa mahabang panahon. Ang pagsasama-sama ng iba't ibang paggamot ay pinakamahusay na gumagana.
Postinflammatory hyperpigmentation (PIH) is a common acquired cutaneous disorder occurring after skin inflammation or injury. It is chronic and is more common and severe in darker-skinned individuals (Fitzpatrick skin types III–VI). While the condition typically improves spontaneously, this process can take months to years, necessitating prolonged treatment. Combination therapy is the most effective.
Postinflammatory hyperpigmentation (PIH) is a common acquired cutaneous disorder occurring after skin inflammation or injury. It is chronic and is more common and severe in darker-skinned individuals (Fitzpatrick skin types III–VI). While the condition typically improves spontaneously, this process can take months to years, necessitating prolonged treatment. Combination therapy is the most effective.
Postinflammatory hyperpigmentation is a common sequelae of inflammatory dermatoses that tends to affect darker skinned patients with greater frequency and severity. Epidemiological studies show that dyschromias, including postinflammatory hyperpigmentation, are among the most common reasons darker racial/ethnic groups seek the care of a dermatologist. The treatment of postinflammatory hyperpigmentation should be started early to help hasten its resolution and begins with management of the initial inflammatory condition. First-line therapy typically consists of topical depigmenting agents in addition to photoprotection including a sunscreen. Topical tyrosinase inhibitors, such as hydroquinone, azelaic acid, kojic acid, arbutin, and certain licorice extracts, can effectively lighten areas of hypermelanosis. Other depigmenting agents include retinoids, mequinol, ascorbic acid, niacinamide, N-acetyl glucosamine, and soy with a number of emerging therapies on the horizon. Topical therapy is typically effective for epidermal postinflammatory hyperpigmentation; however, certain procedures, such as chemical peeling and laser therapy, may help treat recalcitrant hyperpigmentation. It is also important to use caution with all of the above treatments to prevent irritation and worsening of postinflammatory hyperpigmentation.
